Physician

Tien Phuc DO, M.D.

According to 2025 Medicare claims, Tien DO, M.D. (NPI: 1134532286) practices medical oncology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (NPI: 1760590962; TIN: 65-0825133) and primary practice location at 32308-5333.

DO's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 86 traditional Medicare patients, billed 31,779 HCPCS/CPT codes, and received $223,276 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 188 prescription claims across 57 beneficiaries totaling $508,704 in drug costs, led by Aprepitant (Aprepitant). 2022 DME data shows 13 claims. Open Payments data shows 80 records totaling $1,578. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $34,644 to $223,276. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	157	531	$34,644
2016	252	768	$52,859
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	405	649	$43,262
2021	489	1,049	$71,080
2022	467	1,024	$64,148
2023	350	18,404	$338,031
2024	86	31,779	$223,276

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	46	87	$1,973
2016	68	187	$11,517
2017	48	108	$10,254
2018	68	190	$25,093
2019	20	40	$3,858
2020	116	492	$1,957,730
2021	133	685	$2,840,402
2022	114	437	$1,947,884
2023	104	342	$1,110,607
2024	57	188	$508,704

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	12	$1,095
2021	N/R	N/R	N/R
2022	N/R	13	$1,361
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	33	33	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	26	38	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	53	89	$67
36415	Insertion of needle into vein for collection of blood sample	76	167	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	74	165	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Aprepitant	Aprepitant	11	154	$3,411
Letrozole	Letrozole	20	856	$675
Dexamethasone	Dexamethasone	11	272	$235
Ondansetron Hcl	Ondansetron Hcl	12	143	$181
Prochlorperazine Maleate	Prochlorperazine Maleate	12	109	$110

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$1,578	Merck Sharp & Dohme LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tien Phuc DO, M.D.?

Tedicare shows public-source Medicare data for Tien Phuc DO, M.D. (NPI 1134532286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tien Phuc DO, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Tien Phuc DO, M.D.?

Tien Phuc DO, M.D. is linked to FLORIDA CANCER SPECIALISTS & RESEARCH INSTITUTE, LLC (billing NPI 1760590962) in the available physician profile data.

Does Tien Phuc DO, M.D. have Open Payments data?

Tien Phuc DO, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.